While the majority of animals (humans included) roam the Earth, some of nature’s most fascinating creatures spend their lives ...
UCB, a global biopharmaceutical company, today announced new three-year data from Phase 3 trials, and their open-label extensions, investigating BIMZELX® (bimekizumab-bkzx) in adults with active ...